Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ ICL Group Ltd. (ICL) Stock Forecast & Price Prediction Israel | NYSE | Basic Materials | Agricultural Inputs
$5.32
-0.07 (-1.30%)Did ICL Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if ICL is one of their latest high-conviction picks.
Based on our analysis of 5 Wall Street analysts, ICL has a neutral consensus with a median price target of $5.75 (ranging from $5.40 to $6.00). The overall analyst rating is Buy (6.0/10). Currently trading at $5.32, the median forecast implies a 8.1% upside. This outlook is supported by 0 Buy, 4 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Benjamin Theurer at Barclays, projecting a 12.8% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for ICL.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 13, 2025 | Barclays | Benjamin Theurer | Equal-Weight | Maintains | $6.00 |
| Jul 2, 2025 | Morgan Stanley | Nigel Dally | Equal-Weight | Maintains | $6.20 |
| Mar 5, 2025 | Barclays | Benjamin Theurer | Equal-Weight | Maintains | $7.00 |
| Feb 27, 2025 | BMO Capital | Joel Jackson | Market Perform | Maintains | $6.50 |
| Jan 21, 2025 | Barclays | Benjamin Theurer | Equal-Weight | Upgrade | $6.00 |
| Aug 16, 2024 | Barclays | Benjamin Theurer | Underweight | Maintains | $4.00 |
| Mar 1, 2024 | Barclays | Benjamin Theurer | Underweight | Maintains | $4.50 |
| Jan 12, 2024 | Barclays | Benjamin Theurer | Underweight | Downgrade | $4.00 |
| Nov 14, 2023 | Barclays | Benjamin Theurer | Overweight | Upgrade | $6.50 |
| Jul 19, 2023 | Morgan Stanley | Nigel Dally | Equal-Weight | Reiterates | $7.00 |
| Jun 1, 2023 | Barclays | Benjamin Theurer | Equal-Weight | Maintains | $7.00 |
| May 30, 2023 | Morgan Stanley | Nigel Dally | Equal-Weight | Maintains | $7.00 |
| May 12, 2023 | BMO Capital | Joel Jackson | Market Perform | Maintains | $8.00 |
| Apr 14, 2023 | Barclays | Benjamin Theurer | Equal-Weight | Maintains | $8.00 |
| Apr 12, 2023 | Morgan Stanley | Nigel Dally | Equal-Weight | Maintains | $7.50 |
| Jan 27, 2023 | Barclays | Benjamin Theurer | Equal-Weight | Maintains | $10.00 |
| Jan 11, 2023 | Morgan Stanley | Vincent Andrews | Equal-Weight | Maintains | $8.50 |
| Nov 17, 2022 | Barclays | Benjamin Theurer | Equal-Weight | Maintains | $11.00 |
| Nov 10, 2022 | BMO Capital | Joel Jackson | Market Perform | Maintains | $9.50 |
| Jul 28, 2022 | BMO Capital | Joel Jackson | Market Perform | Maintains | $11.00 |
The following stocks are similar to ICL based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
ICL Group Ltd. has a market capitalization of $6.87B with a P/E ratio of 29.6x. The company generates $7.15B in trailing twelve-month revenue with a 3.2% profit margin.
Revenue growth is +6.2% quarter-over-quarter, while maintaining an operating margin of +6.3% and return on equity of +4.6%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Produces specialty minerals and chemicals.
ICL Group Ltd. generates revenue through the development, production, and marketing of specialty minerals and chemicals, focusing on potash, phosphate, and bromine products. These products are essential for fertilizers, industrial applications, and food ingredients, thereby catering to a diverse range of sectors including agriculture and chemicals.
Headquartered in Tel Aviv, Israel, ICL operates across multiple segments with a strong presence in Europe, North and South America, and Asia. The company emphasizes sustainable practices and innovative solutions to address resource scarcity and adapt to changing industry standards.
Basic Materials
Agricultural Inputs
12,165
Mr. Elad Aharonson
Israel
2014
ICL Group has launched a specialty fertilizer plant in India to enhance supply chain efficiency, customize products, and address the growing demand for sustainable crop solutions.
ICL Group's new plant in India enhances supply chain efficiency, targets a growing market, and underscores a focus on sustainability, potentially leading to increased revenues and market share.
ICL has opened a new specialty fertilizer production facility in Maharashtra, India, addressing supply disruptions amid geopolitical instability and reliance on fertilizer imports.
ICL's new facility in India addresses local fertilizer supply disruptions, enhancing its market position and potential revenue growth amid geopolitical uncertainties.
ICL Group Ltd. announced Asaf Alperovitz will be appointed CFO starting June 15, 2026, succeeding Aviram Lahav, who is retiring.
Leadership changes can impact a company's strategy and performance. Investors may reassess ICL Group's future prospects and stability with a new CFO joining in 2026.
ICL filed its annual report on Form 20-F for FY 2025 with the SEC. The report is available on the SEC and ICL's websites for shareholder access.
ICL's annual report filing provides financial transparency, critical for assessing company performance, potential growth, and investment risks, influencing investor confidence and stock valuation.
ICL Group Ltd reported its Q4 2025 earnings, detailing financial performance and insights. For specific figures and outcomes, refer to the full earnings call transcript.
ICL Group's Q4 2025 earnings call provides insights into financial performance, strategic direction, and market conditions, influencing stock valuation and investment decisions.
ICL reported Q4 2025 sales of $1.701 billion, up 6% YoY. Operating income decreased to -$16 million, but adjusted operating income rose 17% to $223 million compared to Q4 2024.
ICL's Q4 results show rising sales but declining operating income, highlighting potential concerns about profitability despite increased adjusted earnings. This may influence investor sentiment and stock performance.
Based on our analysis of 5 Wall Street analysts, ICL Group Ltd. (ICL) has a median price target of $5.75. The highest price target is $6.00 and the lowest is $5.40.
According to current analyst ratings, ICL has 0 Buy ratings, 4 Hold ratings, and 0 Sell ratings. The stock is currently trading at $5.32. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict ICL stock could reach $5.75 in the next 12 months. This represents a 8.1% increase from the current price of $5.32. Please note that this is a projection by Wall Street analysts and not a guarantee.
ICL Group Ltd. generates revenue through the development, production, and marketing of specialty minerals and chemicals, focusing on potash, phosphate, and bromine products. These products are essential for fertilizers, industrial applications, and food ingredients, thereby catering to a diverse range of sectors including agriculture and chemicals.
The highest price target for ICL is $6.00 from Benjamin Theurer at Barclays, which represents a 12.8% increase from the current price of $5.32.
The lowest price target for ICL is $5.40 from at , which represents a 1.5% increase from the current price of $5.32.
The overall analyst consensus for ICL is neutral. Out of 5 Wall Street analysts, 0 rate it as Buy, 4 as Hold, and 0 as Sell, with a median price target of $5.75.
Stock price projections, including those for ICL Group Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.